Inventor · disambiguated record
Erez Feige
Also filed as: FEIGE EREZ
9 granted patents·6 pending applications·30 citations·filing 2009–2022
86Inventor score
Top patents by PatentIndex Score
15 records- 0191US11697682B2Motile sperm domain containing protein 2 antibodies and methods of use thereofVASCULAR BIOGENICS LTD·Filed 2021·Granted Jul 11, 2023·2 cites·29 claims
- 0289US10383954B2Methods of inducing responsiveness to anti-angiogenic agentVASCULAR BIOGENICS LTD·Filed 2017·Granted Aug 20, 2019·4 cites·18 claims
- 0387US9682154B2Methods of inducing responsiveness to anti-angiogenic agentVASCULAR BIOGENICS LTD·Filed 2014·Granted Jun 20, 2017·6 cites·20 claims
- 0482US11191848B2Methods of inducing responsiveness to anti-angiogenic agentVASCULAR BIOGENICS LTD·Filed 2019·Granted Dec 7, 2021·1 cites·16 claims
- 0581US11311583B2Treatment methods using adenovirusVASCULAR BIOGENICS LTD·Filed 2018·Granted Apr 26, 2022·1 cites·11 claims
- 0679US9567605B2Methods for use of a specific anti-angiogenic adenoviral agentCOHEN YAEL·Filed 2011·Granted Feb 14, 2017·4 cites·26 claims
- 0778US9200056B2FAS-chimera adenovirus vectorVASCULAR BIOGENICS LTD·Filed 2014·Granted Dec 1, 2015·3 cites·23 claims
- 0876US9206206B2Oxidized lipid compounds and uses thereofKOVALEVSKI-ISHAI ETI·Filed 2009·Granted Dec 8, 2015·5 cites·28 claims
- 0974US8999960B2Oxidized thiophospholipid compounds and uses thereofBREITBART EYAL·Filed 2009·Granted Apr 7, 2015·4 cites·35 claims
- 1071US2022331383A1Treatment methods using adenovirusVASCULAR BIOGENICS LTD·Filed 2022·Application pending·0 cites
- 1160US2013280217A1Methods for Use of a Specific Anti-Angiogenic Adenoviral AgentVASCULAR BIOGENICS LTD·Filed 2013·Application pending·0 cites
- 1260US2013280216A1Methods for Use of a Specific Anti-Angiogenic Adenoviral AgentVASCULAR BIOGENICS LTD·Filed 2013·Application pending·0 cites
- 1351US2016143968A1Treatment methods using adenovirusVASCULAR BIOGENICS LTD·Filed 2015·Application pending·0 cites
- 1448US2013203707A1Oxidized Lipid Compounds and Uses ThereofVASCULAR BIOGENICS LTD·Filed 2013·Application pending·0 cites
- 1538US2015320773A1Treatment of inflammationVASCULAR BIOGENICS LTD·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →